Femtech World’s Post

Something exceptional had to come up for me to travel in April. And then BOOM happened! 💙 Right in the middle of Europe's innovation heart, how could I resist? Join us next week in Basel (10th-11th April) for the first edition of the BOOM Summit! The event will unite healthcare professionals, thought leaders, venture capital #investors, and #startup #founders for two days of insightful discussions and networking opportunities. Can you guess what my catalyser session will drum about? Commercialization of #healthtech. Top tips and flops. 😎 Still not sure this event is for you? Let me inspire you. 🟣 WHY YOU SHOULD COME Switzerland tops the Global Innovation Index. Pharmaceuticals and life sciences are key drivers with a strong focus on biopharmaceuticals, medical devices, and precision medicine. The BioValley in Basel is one of Europe’s healthcare hotspots. Basel's strategic location at the heart of Europe and its access to exceptional talent, R&D and funding have been instrumental in its success. Market leaders such as Novartis, Roche, Lonza, Bayer, BASF, Syngenta, Straumann or Moderna have their HQ or important divisions there. Supporting them, an ecosystem of biotechnology, nanotechnology, IT and communication technologies is thriving. So: Are you looking for R&D, innovations, partners, investors ❓ Wonder how you could add value to that ecosystem ❓ Want to improve R&D or services with the right technology partners❓ Then: 🟣 COME AND JOIN US! The Why, What and Who will be brought to you by Day One under one umbrella. You can register in the link below. (Use the code BOOM24 for 15% off your ticket) 💜 What does your #healthtech heart beat sound like? Mine already sounds like Boom :) (PS: Amazing pop art banner too). Thanks Ursula Costa, Pascal Clisson, Caoimhe Vallely-Gilroy and Rebecca Nordstrom and the DayOne - Healthcare Innovation team for this opportunity! Bis Bald? Gilles, Philippe, Aline, René, Monica,Yannick, Laura, Nikola and those living nearby? (I will also be passing by Zurich). i-Expand #commercialization #biotechology #healthcare #healthtech #digitalhealth

How can design increase people's ability to take action within digital health? 🎉 This is the talk opportunity I've been waiting for a while. Many digital health products invest primarily in medical and tech, which is fair but leaves user experience to chance and guesses. User experience is highly linked to engagement and how a product can transform your life, which, in health, is equal to adherence, increased efficacy and quality of life. If your users can't take action, your product will fail, no matter what. I will be talking about what drives us to try new solutions and give some practical usability examples to put all chances on your side when people decide to engage with your digital solution. 👋 See you in Boston at the LSX - partnering for Life Science eXecutives conference :)  #productdesign #usability #lsxWorldCongress #digitalhealth #biotech #medtech #healthtech #digitalhealth https://lnkd.in/esVMbdB

Interesting white paper that addresses paths to finance innovation in #womenshealth 👇 https://lnkd.in/eCDn9Pfm Powered by Catenion in partnership with Roche and FemTechnology Summit Totally echo the need to engage all stakeholders, from policy makers, public bodies, investors to healthcare professionals (just to name a few). Concrete actions are missing and is the reason why #initiatives such as the Collective’s task force on ‘Access to Funding’ have been triggered (https://lnkd.in/e-fPcPg8) Interested to learn more and/or want to help foster innovation in #femtech ? Join us at next Tech4Eva - The global Femtech accelerator closing ceremony (link in comment) and/or let’s engage offline. #innovation #womenshealth #healthcare #financing #support #accelerate #transform #partnernships #collaboration Liliane Brunner Halbach, Oriana Kraft Karolina Fratczak, Patrycja Pielaszek, Pirmin Meyer, Luzia Schuler, Cynthia Jurytko, Maria-Luisa Fuchs, Karen Wendt, Melanie Kovacs, Lan Zuo Gillet, Simone Theiss, Michanne Steenbergen, Rosana Rabines, Katja Baur, Désirée Dosch, Jack Bowman

TODAY at RESI (2:00-2:50pm, Boston Park Plaza) Strategic Partners Panel - Looking Beyond Traditional Equity Investments For early-stage companies seeking to move their companies forward, strategic partners are not only a potential exit, but can lend expertise and resources. Outside of co-development, licensing can provide an alternate source of funding, allowing companies to take their pipeline in one direction, while a strategic develops it in another. Hear from strategics how the choose a particular path for their partnerships, what requirements they have, and at what stage it makes sense for a company to approach them. Fiona Mack (Moderator) - VP, Head of Bayer Co.Lab Cambridge, US Dov Shamir, Ph.D. - Head, Elementa Labs; Mount Sinai Innovation Partners Alex de Winter - Vice President of New Ventures; Danaher Ventures Tingting Zhang-Kharas, PhD - Head, Johnson & Johnson Innovation Michael Hansen - Innovation Scouting Director – North America; Eppendorf https://lnkd.in/e_2c3gGb #earlystagestartups #earlystageinvesting #paneldiscussion #strategicpartnerships

Healthcare entrepreneurship is assuming an even greater role in driving innovation and sustainable solutions across the biotechnology industry. From the inception of fresh ideas and groundbreaking technologies to harnessing the power of transformation, Hayat Biotech is working towards reshaping healthcare as we know it.   Our CEO, Naser Al Yammahi, in an exclusive interview with Omnia Health, shares his experience as a leading healthcare entrepreneur and his commitment to building a sustainable future through the power of collaboration and innovation. Read the full article here https://lnkd.in/dGEBJ_jb #HealthcareBusinessGrowth #IndustryInnovations #ExpertAdvice #SustainableHealthcare #HayatBiotech #Hayatbiotech #Omniahealth

The landscape of #Biopharma #Research is undergoing a profound transformation, and it's a moment we can't afford to overlook. For far too long, the industry has grappled with challenges like low productivity, high failure rates, and interminable development timelines. But as patent cliffs loom and the pressure to replenish drug pipelines intensifies, the time for change is now. Enter #DigitalHealth tools—the long-awaited game-changer. These cutting-edge innovations are not just reshaping biopharma research; they're catapulting traditional companies into the forefront of technological progress. The numbers speak volumes. #Partnerships between Biopharma and Digital Health ventures have skyrocketed 3.9 times from 2018 to 2023. What's particularly striking is the shift in focus within these collaborations. While #PatientSolutions and #MedicalDiagnostics held sway in 2018, #ResearchSolutions now command the spotlight, comprising 32% of partnerships in 2023. But amidst this wave of innovation, it's crucial to cut through the noise and discern the true trends shaping our industry's future. That's where Galen Growth | Insights You Can Trust's latest in-depth analysis comes in. Dive deep into biopharma's hottest innovation focus, separating fact from fiction and pinpointing the trailblazers and rising stars leading the charge. Are you ready to seize the opportunities presented by Digital Health? Join us at HealthTech Alpha—an unparalleled platform designed to equip you with the insights and tools needed to thrive in this dynamic landscape. Leverage cutting-edge data and propel your organisation ahead of the curve. Subscribe to HealthTech Alpha today and chart a course towards success in Digital Health! #Partnerships #DigitalHealth

🌐 Collaboration Partners Highlighted: Discover Our Expanded Network! In line with the UMCG's mission, our goal is to serve as a one-stop-shop for innovation, strengthening our ability to be an engine regionally and nationally. There are several areas of expertise, strategic partnerships and ecosystems, on which the UMCG Innovation Center is involved in – may it be as a coordinating locus, or a supporting partner. 🔎 Each strategic partnership operates within its own unique landscape - based on an interconnected network of individuals, research organizations, public and private entities - addressing complex challenges in healthcare, MedTech, sustainability, drug development etc. Yet, through collaboration and innovation within these specialised ecosystems, we collectively advance towards transformative breakthroughs. 🔗 We invite you to explore our website and learn more about the UMCG partnerships shaping the healthcare innovation! PCH Ecosysteem Lifelines_NL Hi!Noord MAECON UMCG ExquAIro HTRIC #UMCGInnovation #HealthcareInnovation #Collaboration #Partnerships

We're proud to be a #mediapartner of the LSX World Congress — Connecting #Innovation with #Capital. The #event takes place from 29–30 April in London, with 2000+ attendees joining. The 10th LSX World Congress gathers the founders and CEOs of innovative #biotech, #medtech and #healthtech #startups through to healthcare giants, and everyone in between. They attend alongside the sector’s most active #investors, #pharma, medtech and healthtech BD&L teams and R&D leaders. #LSXWorld brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there? Find out more 👉 https://lnkd.in/ddbtpquX LSX - partnering for Life Science eXecutives #messengersinscience

These numbers are not acceptable. We need more than 3% of investment dollars in healthcare to be put towards diagnostics – because early diagnosis saves lives. Check out my article in @Med Device Online for strategies for diagnostic #startups to increase their chances of success in fundraising.

Come and join us to the Sidley Global Life Sciences Healthcare Investment Conference taking place on 12 September 2023 at The Francis Crick Institute in London with key industry speakers who will share insights on hot topics, trends and opportunities to grab. I hope to see many of you there ( see below for more information). Robert Darwin #lifesciences #investments #privateequity #deals #venturecapital